The Rocket's Next Ascent: Is SpaceX Gearing Up for a Landmark IPO, with Goldman Sachs Leading the Charge?
The Road Ahead for Semaglutide Generics: Why API Capacity Is the Real Game‑Changer, Says Goldman Sachs